Key Takeaways
- Quantum Computing (QUBT) releases Q4 FY25 earnings on March 2, 2026
- Analysts forecast a $0.02 per share loss, significantly improved from the $0.47 loss reported one year earlier
- Projected revenue stands at $390K, representing substantial growth from $62K in Q4 2024
- Shares declined 8.4% on February 27, now trading beneath both 50-day and 200-day moving averages
- Option market activity suggests a potential 14.05% price swing following the earnings announcement
Quantum Computing Inc. prepares to unveil its Q4 FY25 financial results on Monday, March 2, 2026. Shares experienced a challenging session ahead of the announcement, sliding 8.4% on February 27 to settle at $8.278.
Daily trading activity reached approximately 3.37 million shares — representing a decline of roughly 78% from the typical session volume of 15 million. Such reduced-volume declines can signal weaker market participation, though additional context matters.
Shares currently trade beneath the 50-day moving average of $10.35 and the 200-day moving average of $13.70. Despite recent weakness, QUBT maintains year-over-year gains exceeding 39%, fueled primarily by enthusiasm surrounding its photonic technology platform.
Analysts project a quarterly loss of $0.02 per share for Q4 2025. This represents meaningful improvement compared to the $0.47 per share loss recorded during the corresponding period last year.
Revenue projections stand at $390K, showing growth from the $62K figure posted in Q4 2024. Though absolute numbers remain modest, the trajectory captures analyst attention.
Luminar Deal Takes Center Stage
A major narrative surrounding the upcoming call centers on the company’s $110 million all-cash purchase of Luminar Semiconductor Inc., formerly part of Luminar Technologies. This transaction aims to enhance QUBT’s vertical integration and establish more predictable revenue streams.
Market participants will pay close attention to management commentary regarding chip manufacturing schedules, fulfillment of existing orders, and preliminary revenue indicators stemming from the acquisition.
Price Targets See Downward Revisions
Analyst perspectives present a varied landscape. Lake Street’s Max Michaelis maintained a Buy recommendation while adjusting his price objective from $24 down to $16 — suggesting approximately 77% appreciation potential from recent trading levels.
Ascendiant Capital Markets similarly reduced its target from $40 to $25 while preserving a Buy stance. Wedbush launched coverage with a Neutral rating alongside a $12 price objective, and Cantor Fitzgerald reaffirmed a Neutral view with a $15 target.
Rosenblatt Securities initiated coverage during January with a Buy rating and $22 price target. The overall consensus reflects a Moderate Buy stance, comprising one Strong Buy, two Buys, two Holds, and one Sell rating among monitored analysts.
The mean price target across all firms reaches $18.00, implying potential upside of approximately 99% from the February 27 closing price.
QUBT demonstrates a beta coefficient of 3.44, indicating heightened volatility relative to broader market movements. The company commands a market capitalization near $1.83 billion, with a negative P/E ratio of -13.40 due to its current pre-profit phase.
Company insiders control 19.3% of outstanding shares. COO Milan Begliarbekov divested 2,860 shares on January 7 at $11.85 per share, decreasing his holdings by approximately 10.55%. Institutional investors hold just 4.26% of shares.
Options pricing models anticipate a stock movement of roughly 14.05% in either direction after the earnings disclosure.
Q4 FY25 financial results will be released before market opening on March 2, 2026.
